Modulation of AMPK significantly alters uveal melanoma tumor cell viability

Deliktas, O; Gedik, ME; Koc, I; Gunaydin, G; Kiratli, H

Kiratli, H (通讯作者),Hacettepe Univ, Med Sch, Dept Ophthalmol, TR-06100 Ankara, Turkiye.;Gunaydin, G (通讯作者),Hacettepe Univ, Canc Inst, Dept Basic Oncol, TR-06100 Ankara, Turkiye.;Gunaydin, G (通讯作者),Dana Farber Canc Inst, 450 Brookline Ave, Boston, MA 02115 USA.

OPHTHALMIC RESEARCH, 2023; 66 (1): 1230

Abstract

Introduction Uveal melanoma (UM) responds poorly to targeted therapies or immune-checkpoint inhibitors. AMP-activated protein kinase (AMPK) is a pivot......

Full Text Link